Perfuze
Galway City, IE · Founded 2018 · 49 employees on LinkedIn · 9 known investors
Find your way into Perfuze
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy. The company is a medical technology firm based in Ireland with clinical partnerships in the US and Europe.
Founders & leadership
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins.
Investors · 9
Seroba Life SciencesDublin · $540K – $7.6M
SV Health InvestorsBoston · $1M – $20M
Enterprise IrelandreportedDublin
EQT Life SciencesreportedLuxembourg · $11M – $66M
Also in the syndicate · 5
EarlybirdleadLSPleadSerobaleadSV Healthleadthe HBM-MedFocus Fund
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AFeb 2022 · 2 sources
LSP (lead), Seroba Life Sciences (lead), Earlybird, Enterprise Ireland, SV Health Investors, the HBM-MedFocus Fund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 1
by search overlap
Companies competing with Perfuze for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Perfuze do?
- Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy. The company is a medical technology firm based in Ireland with clinical partnerships in the US and Europe.
- Who founded Perfuze?
- Perfuze was founded by Wayne Allen, Liam Mullins in 2018.
- Who are Perfuze's investors?
- Perfuze's investors include Seroba Life Sciences, SV Health Investors, Enterprise Ireland, EQT Life Sciences.
- Where is Perfuze headquartered?
- Perfuze is headquartered in Galway City, IE.